Background
Established well known Adipokines
Adipokine | Association with obesity and/or T2D in humans | Adipokine effect on insulin signalling in animal models | Adipokine effect on insulin signalling in human skeletal muscle | |
---|---|---|---|---|
In Vivo | In Vitro | |||
Leptin | Overexpression of leptin in a skinny mouse model increased insulin sensitivity [29]. Administration of leptin (12–15 days) reversed insulin resistance in obese wistar rats [128]. Leptin reversed high fat diet induced skeletal muscle insulin resistance in rats, indirectly via reducing intramuscular triglycerides not though direct modulation of insulin signalling [129]. | Recombinant leptin reduces IRS-1 phosphorylation and glucose uptake in L6 myotubes [27]. | Increased phosphorylation of AKT in commercially available primary human myotubes [30]. | |
Recombinant leptin increased glucose uptake in C2C12 myotubes [28]. Acute (10mins-1 h) stimulation of L6 Myotubes directly increased glucose uptake via a PI3K-dependent pathway. Leptin pre-treatment (10 min) of L6 myotubes inhibits insulin stimulated glucose uptake [130]. 24 h Pre-treatment of L6 myotubes had no effect on glucose uptake but did inhibit adiponectin stimulated glucose uptake [131]. | ||||
Adiponectin | Induces fat oxidation through activation of AMPK in myotubes from lean subjects. Mechanism impaired in myotubes from T2D patients [41]. | |||
Recombinant adiponectin increased glucose uptake via AMPK mediated reorganisation of the actin cytoskeleton and GLUT4 translocation via an independent mechanism [130]. | ||||
Resistin | Administration of resistin (6 days) to wild type mice induces a state of insulin resistance [132]. | Unknown | ||
Targeted reduction of resistin in insulin resistant mice via antisense oligodeoxynucleotide restored hepatic but not skeletal muscle insulin sensitivity [133]. | ||||
Visfatin | Visfatin overexpression in rats increased whole body insulin sensitivity and adipose tissue and liver IRS-1 phosphorylation in response to insulin [56]. | Stimulated glucose uptake and increased GLUT4 membrane translocation and mRNA and protein expression in C2C12 myotubes via AMPK p38 MAPK signalling [57]. | Unknown | |
Increased glucose uptake in rat EDL muscle [137]. |
Leptin
Adiponectin
Resistin
Visfatin
Novel Adipokines
Adipokine | Association with obesity and/or T2D in humans | Adipokine effect on insulin signalling in animal models | Adipokine effect on insulin signalling in human skeletal muscle | |
---|---|---|---|---|
In Vivo | In Vitro | |||
FGF-21 | Increased [86]. | Increased insulin sensitivity and glucose uptake in mice, via FGF-21 mediated increases in adiponectin production and secretion from adipocytes [76]. | 6 h incubation of mouse EDL muscle with FGF-21 resulted in a 54% increase in insulin stimulated glucose uptake [86]. | Directly increased glucose uptake in primary human myotubes [86]. Prevents palmitate-induced insulin resistance in primary human myotubes by inhibiting stress kinases and NF-κB [87]. |
Continuous cerebral administration for 2 weeks increased whole body insulin sensitivity in rats with dietary induced obesity [77]. | ||||
Daily administration for 6 weeks improved glucose handling in diabetic rhesus monkeys [78]. | ||||
Chemerin | Overexpression increased insulin resistance in LDL receptor deficient mice by reducing AKT phosphorylation in response to insulin in skeletal muscle, but not liver or pancreas [96]. | 24 h pre-treatment reduces insulin stimulated glucose uptake in C2C12 myotubes in a dose dependent manor [99]. | 24 h chemerin Increased insulin resistance and reduced insulin stimulated glucose uptake in primary human myotubes, mediated by increased ERK signalling [95]. | |
knockout mice display increased skeletal muscle insulin resistance while transgenic mice exhibit increased skeletal muscle insulin resistance [98]. | ||||
Acute chemerin treatment exacerbated glucose intolerance and lowered serum insulin levels in obese and diabetic mice. No effect observed in normoglycemic mice [97]. | ||||
CTRP3 | Administration of recombinant CTRP3 directly lowers glucose levels in normal and insulin-resistant ob/ob mice [140]. | Administration of recombinant CTRP3 to L6 myotubes had no effect on glucose uptake [140]. | Unknown | |
Overexpression of CTRP3 improved insulin sensitivity in HFD fed mice [141]. | Increased glucose uptake and GLUT 4 mRNA expression in insulin resistant adipocytes [142]. | |||
RBP4 | Overexpression or direct administration of RBP4 increased insulin resistance in mice. RBP4 knockout improves insulin sensitivity in mice [144]. | unknown | Unknown | |
Reducing circulating RBP4 in obese mice models improved glucose tolerance and increased insulin stimulated glucose uptake in skeletal muscle up to 60% [145]. | ||||
Vaspin | Unknown | Unknown | ||
transgenic mice overexpressing vaspin displayed improved glucose tolerance and were protected from obesity when challenged with a high fat diet [62]. | ||||
Pref-1 | Increased [101]. | Overexpression in mice drives insulin resistance via decreased adipose tissue and skeletal muscle glucose uptake and impaired skeletal muscle insulin signalling [105]. | Unknown | 4 Day exposure to primary human myotubes from lean, obese and T2D subjects had no effect on glucose uptake [106]. |
Follistatin-like 1 | Increased [108]. | Unknown | Blunts insulin signalling-adipocytes [108]. | unknown |
Omentin-1 | Unknown | omentin-1 induced AKT phosphorylation and enhanced insulin-stimulated glucose uptake in human adipocytes [123]. | Unknown Unknown | |
Lipocallin-14 | Unknown | Over expression in diet induced obese mice reduced glucose and insulin levels while improving glucose tolerance [124]. | Unknown |